DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $29,266,000 | +2.6% | 7,316,604 | +25.7% | 0.00% | 0.0% |
| Q3 2019 | $28,524,000 | -17.9% | 5,821,271 | +2.0% | 0.00% | 0.0% |
| Q2 2019 | $34,764,000 | +8.3% | 5,708,105 | +3.4% | 0.00% | 0.0% |
| Q1 2019 | $32,087,000 | -57.8% | 5,522,674 | -2.3% | 0.00% | -66.7% |
| Q4 2018 | $76,107,000 | -28.2% | 5,654,319 | +3.5% | 0.00% | -25.0% |
| Q3 2018 | $106,011,000 | -21.0% | 5,461,715 | +4.0% | 0.00% | -33.3% |
| Q2 2018 | $134,235,000 | +41.3% | 5,251,776 | +11.4% | 0.01% | +50.0% |
| Q1 2018 | $95,004,000 | +5.9% | 4,714,875 | +5.4% | 0.00% | 0.0% |
| Q4 2017 | $89,747,000 | +0.9% | 4,471,658 | +4.2% | 0.00% | 0.0% |
| Q3 2017 | $88,917,000 | +47.4% | 4,293,467 | +5.3% | 0.00% | +33.3% |
| Q2 2017 | $60,342,000 | -2.2% | 4,077,145 | +5.4% | 0.00% | 0.0% |
| Q1 2017 | $61,676,000 | +44.6% | 3,866,811 | +14.2% | 0.00% | +50.0% |
| Q4 2016 | $42,652,000 | -56.7% | 3,385,101 | -3.7% | 0.00% | -66.7% |
| Q3 2016 | $98,509,000 | -15.6% | 3,516,924 | +5.5% | 0.01% | -14.3% |
| Q2 2016 | $116,690,000 | +39.9% | 3,334,010 | +9.5% | 0.01% | +40.0% |
| Q1 2016 | $83,418,000 | -9.6% | 3,044,439 | +13.0% | 0.01% | -16.7% |
| Q4 2015 | $92,226,000 | -79.2% | 2,695,086 | -80.1% | 0.01% | -64.7% |
| Q3 2015 | $443,300,000 | +390.8% | 13,545,352 | +571.1% | 0.02% | +183.3% |
| Q2 2015 | $90,322,000 | +104.5% | 2,018,371 | +58.0% | 0.01% | +100.0% |
| Q1 2015 | $44,174,000 | +142.1% | 1,277,440 | +91.6% | 0.00% | +200.0% |
| Q4 2014 | $18,245,000 | – | 666,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|